beta(2)-Glycoprotein I: a novel component of innate immunity

Cetin Agar, Philip G. de Groot, Matthias Mörgelin, Stephanie D. D. C. Monk, Gwendolyn van Os, Johannes H. M. Levels, Bas de Laat, Rolf T. Urbanus, Heiko Herwald, Tom van der Poll, Joost C. M. Meijers

Research output: Contribution to journalArticlepeer-review

74 Citations (SciVal)


Sepsis is a systemic host response to invasive infection by bacteria. Despite treatment with antibiotics, current mortality rates are in the range of 20%-25%, which makes sepsis the most important cause of death in intensive care. Gram-negative bacteria are a prominent cause of sepsis. Lipopolysaccharide (LPS), one of the major constituents of the outer membrane of Gram-negative bacteria, plays a major role in activating the host's immune response by binding to monocytes and other cells. Several proteins are involved in neutralization and clearance of LPS from the bloodstream. Here, we provide evidence that beta(2)-glycoprotein I (beta(2)GPI) is a scavenger of LPS. In vitro, beta(2)GPI inhibited LPS-induced expression of tissue factor and IL-6 from monocytes and endothelial cells. Binding of beta(2)GPI to LPS caused a conformational change in beta(2)GPI that led to binding of the beta(2)GPI-LPS complex to monocytes and ultimately clearance of this complex. Furthermore, plasma levels of beta(2)GPI were inversely correlated with temperature rise and the response of inflammatory markers after a bolus injection of LPS in healthy individuals. Together, these observations provide evidence that beta(2)GPI is involved in the neutralization and clearance of LPS and identify beta(2)GPI as a component of innate immunity. (Blood. 2011;117(25):6939-6947)
Original languageEnglish
Pages (from-to)6939-6947
Issue number25
Publication statusPublished - 2011

Subject classification (UKÄ)

  • Hematology


Dive into the research topics of 'beta(2)-Glycoprotein I: a novel component of innate immunity'. Together they form a unique fingerprint.

Cite this